Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Lipopolysaccharide amine cationic polymer and preparation method and application thereof

A cationic polymer, lipopolysaccharide technology, applied in the field of biomedicine, can solve the problems of low transfection efficiency, low gene transfection efficiency and virus transfection level, etc., and achieves reduced cytotoxicity, excellent biocompatibility, and improved gene transfection. The effect of dyeing efficiency

Inactive Publication Date: 2012-07-11
THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV +1
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the gene transfection efficiency of this vector is still much lower than that of virus
When using this carrier to carry out in vitro serum-free transfection to mouse Jurkat cells, the highest gene transfection efficiency of its green fluorescent protein (GFP) can only reach about 18%; and when there is serum transfection, its transfection efficiency is even higher less than 1%

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lipopolysaccharide amine cationic polymer and preparation method and application thereof
  • Lipopolysaccharide amine cationic polymer and preparation method and application thereof
  • Lipopolysaccharide amine cationic polymer and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] 1 Synthesis of reduced lipopolysaccharide amine cationic polymer rMASA-PEI-Cho

[0044] 1.1 Synthesis of cholesterol-terminated polyethyleneimine (PEI-Cho)

[0045] First, dichloromethane and PEI with a molecular weight of less than 2k are dehydrated, and then 3g PEI (1.67×10 -3 mol), 10mL dichloromethane, 100μL triethylamine (7.17×10 -3 mol) was fully stirred and mixed on ice for 30 min to obtain a clear and transparent solution A; 0.75 g of cholesterol chloroformate (1.67 × 10 -3 mol, where the molar feed ratio of PEI and cholesterol chloroformate is 1:1. ) was dissolved in 5 mL of ice-cold anhydrous dichloromethane to obtain a transparent and clear solution B. With stirring, solution 2 was slowly added dropwise to solution A within 30 min, and then the reaction mixture was stirred and reacted on ice for 12 h, and the solvent was removed by rotary evaporation to obtain a white very viscous semi-solid. The semi-solid was dissolved in 50 mL of 0.1 mol / L HCl, filtere...

Embodiment 2

[0054] 1 Synthesis of lipopolysaccharide amine cationic graft copolymer MASA-PEI-Cho

[0055] 1.1 Synthesis of cholesterol-terminated polyethyleneimine (PEI-Cho)

[0056] First dehydrate dichloromethane and PEI, then take 3g PEI (1.67×10 -3 mol), 10mL dichloromethane, 200μL triethylamine (1.43×10 -2mol) was fully stirred and mixed on ice for 30 minutes to obtain a clear and transparent solution A; 1.5 g of cholesterol chloroformate (the molar ratio of it to PEI was 2:1) was dissolved in 10 mL of ice-cold anhydrous dichloromethane to obtain a transparent and clear solution b. With stirring, solution B was slowly added dropwise to solution A within 30 min, and then the reaction mixture was stirred on ice for 12 h, and the solvent was removed by rotary evaporation to obtain a white very viscous semi-solid. The semi-solid was dissolved in 50 mL of 0.5 mol / L HCl, filtered, and the filtrate was extracted three times with 100 mL of dichloromethane to remove unreacted cholesterol c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a lipopolysaccharide amine cationic polymer, which is synthesized with hydrophilic polyaldehyde-based sodium alginate is adopted as a main chain, hydrophobic cholesterol capped polyethylene imine of low molecular weight as a side chain. The physical and chemical structure, buffering capacity, transfection efficiency and cytotoxicity of the lipopolysaccharide amine cationic polymer are characterized. According to exploration of the feasibility of use as a gene carrier and the effects on improvement of the gene transfection efficiency and reduction of the cytotoxicity, the polymer has advantages of good biocompatibility, controllable degradation performance, low cytotoxicity, high safety and practicality and low cost, and the transfection efficiency of GFP (green fluorescent protein) in MSCs (mesenchymal stem cells) is higher than 95 percent regardless of the presence or absence of serum. Moreover, the polymer can be used as a gene carrier and other drug carriers such as anticancer drugs, RNA (ribose nucleic acid) carriers and the like. The invention also discloses a preparation method and application of the polymer.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a lipopolysaccharide amine cationic polymer and its preparation method and application. Background technique [0002] Gene therapy will provide unlimited possibilities for the treatment of all gene-related diseases, so it has become a research hotspot in the past two decades. The bottleneck of clinical application of gene therapy is its safety and effectiveness. Since viral vectors have many safety hazards that cannot be predicted and resolved, such as immunogenicity, toxicity, carcinogenicity, and host DNA insertion and integration, non-viral vectors have become the hope for the clinical application of gene therapy. In the past ten years, people have been devoting themselves to designing various new non-viral vectors and studying ways to improve their transfection efficiency while reducing cytotoxicity, and great progress has been made, but there is still a cert...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C08G81/00C08G73/04C08B37/04A61K48/00A61K47/36C12N15/87
Inventor 王琴梅滕伟
Owner THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com